Top

Published in:

Open Access 01-12-2020 | ASO Author Reflections

ASO Author Reflections: Estimating the Prevalence of Pseudomyxoma Peritonei in Europe Using a Novel Statistical Method

Authors: Kjersti Flatmark, MD, PhD, Faheez Mohamed, MD, FRCS

Published in: Annals of Surgical Oncology | Special Issue 3/2020

Excerpt

Pseudomyxoma peritonei (PMP) is an uncommon abdominal cancer characterised by extensive growth of mucinous tumour in the peritoneal cavity. Historically, surgical debulking has been the mainstay of treatment. From the 1980s complete cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) has been developed as a curative treatment strategy, but this approach is resource intensive with the best outcomes in high volume centres1^,2. Lack of reliable epidemiological data has hampered adequate diagnosis and treatment of PMP globally. …

Govaerts K, Lurvink RJ, De Hingh I, et al. Appendiceal tumours and pseudomyxoma peritonei: literature review with PSOGI/EURACAN clinical practice guidelines for diagnosis and treatment. Eur J Surg Oncol. 2020. https://doi.org/10.1016/j.ejso.2020.02.012.CrossRefPubMed

Rajeev R, Klooster B, Turaga KK. Impact of surgical volume of centers on post-operative outcomes from cytoreductive surgery and hyperthermic intra-peritoneal chemoperfusion. J Gastrointest Oncol. 2016;7(1):122–128.PubMedPubMedCentral

Smeenk RM, van Velthuysen ML, Verwaal VJ, Zoetmulder FA. Appendiceal neoplasms and pseudomyxoma peritonei: a population based study. Eur J Surg Oncol. 2008;34(2):196–201.CrossRef

Patrick-Brown TDJH, Carr NJ, Carr DM, et al. Estimating the prevalence of pseudomyxoma peritonei in Europe using a novel statistical method. Ann Surg Oncol. 2020. https://doi.org/10.1245/s10434-020-08655-8.CrossRefPubMed

Kirby R, Liauw W, Zhao J, Morris D. Quality of life study following cytoreductive surgery and intraperitoneal chemotherapy for pseudomyxoma peritonei including redo procedures. Int J Surg Oncol. 2013;2013:461041.PubMedPubMedCentral

Stearns AT, Malcomson L, Punnett G, et al. Long-term quality of life after cytoreductive surgery and heated intraperitoneal chemotherapy for pseudomyxoma peritonei: a prospective longitudinal study. Ann Surg Oncol. 2018;25(4):965–973.CrossRef

Title: ASO Author Reflections: Estimating the Prevalence of Pseudomyxoma Peritonei in Europe Using a Novel Statistical Method
Authors: Kjersti Flatmark, MD, PhD
Faheez Mohamed, MD, FRCS
Publication date: 01-12-2020
Publisher: Springer International Publishing
Published in: Annals of Surgical Oncology / Issue Special Issue 3/2020
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI: https://doi.org/10.1245/s10434-020-08691-4

Keynote webinar | Spotlight on medication adherence

Springer Medicine

ASO Author Reflections: Estimating the Prevalence of Pseudomyxoma Peritonei in Europe Using a Novel Statistical Method

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Special Issue 3/2020

ASO Author Reflections: How Predictive Models Can Help Guide Axillary Surgery Decision Making After Neoadjuvant Chemotherapy

ASO Author Reflections: Is Sentinel Lymph Node Biopsy Necessary in Patients with Ductal Carcinoma In Situ with Microinvasion Diagnosed on Core Biopsy?

ASO Author Reflections: Salvage Total Laryngectomy, the Last Resort for Patients with Residual, Recurrent or Second Primary Laryngeal and Hypopharyngeal Cancer in Times of Nonsurgical Organ Preserving Treatment Strategies

Comments on “Electrochemotherapy with Irreversible Electroporation and FOLFIRINOX Improves Survival in Murine Models of Pancreatic Adenocarcinoma”

ASO Author Reflection: Sentinel Lymph Node Biopsy in Thin Melanoma

ASO Author Reflections: The Oncologic Efficacy and Feasibility of Nephron-Sparing Surgery for Adult Xp11.2 Translocation Renal Cell Carcinoma